Clinical trials
Phase 1 Myelodysplastic Syndromes trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 8 |
| Recruiting | 7 |
| Active, not recruiting | 1 |
| Completed | 1 |
| Suspended | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 3 |
| Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. | 2 |
| iCell Gene Therapeutics | 2 |
| Affiliated Hospital to Academy of Military Medical Sciences | 1 |
| Ascentage Pharma Group Inc. | 1 |
| Beijing InnoCare Pharma Tech Co., Ltd. | 1 |
| Biocity Biopharmaceutics Co., Ltd. | 1 |
| Changchun GeneScience Pharmaceutical Co., Ltd. | 1 |
| Guangzhou Lupeng Pharmaceutical Company LTD. | 1 |
| Hangzhou GluBio Pharmaceutical Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myelodysplastic Syndromes | 19 |
| Leukemia, Myeloid, Acute | 13 |
| Leukemia | 3 |
| Myeloproliferative Disorders | 3 |
| Hematologic Neoplasms | 2 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 |
| Leukemia, Myelomonocytic, Chronic | 2 |
| Lymphoma, B-Cell | 2 |
| Primary Myelofibrosis | 2 |
| Recurrence | 2 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.